Corona Tech

When necessity takes over,innovate

Please note that I am not able to take responsibility or approving the below.

It is some of the research that I have done over the last few months due to unprecedented nature of coronavirus.

https://www.cdc.gov/coronavirus/2019-ncov/hcp/respirator-use-faq.html

https://www.cdc.gov/niosh/npptl/topics/respirators/factsheets/respsars.html

 

Ratings of masks –

https://pksafety.com/blog/respiratory-basics-n95-vs-p100/

 

Respiratory Protection | Dust, FFP1, FFP2, FFP3, Full and Half Face Masks | Protec Direct

 

https://www.sages.org/n-95-re-use-instructions/

https://www.childrenshospital.org/research/departments-divisions-programs/departments/surgery/surgical-innovation-fellowship

https://www.hse.gov.uk/respiratory-protective-equipment/fit-testing-basics.htm

 

indg479[1]

https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-and-surgical-masks-face-masks

Prusa Face Shield : PrusaPrinters

‘shield’ is a bench to fight COVID-19 by antonio lanzillo & partners

Prusa Knowledge Base | Prusa Face Shield disinfection

Usie snorkell masks as PPE

engineers use 3D printing hack to turn scuba masks into ventilators

Italian Engineers Turn Snorkeling Masks Into Life-Saving Ventilators

 

Hoods corridor

https://www.southampton.ac.uk/publicpolicy/support-for-policymakers/policy-projects/perso.page

CPAP

https://www.ucl.ac.uk/healthcare-engineering/covid-19/ucl-ventura-breathing-aids-covid-19-patients

https://www.formula1.com/en/latest/article.mercedes-f1-help-develop-coronavirus-breathing-device-for-health-service-use.6Yx9lt3ADUMLwXr7UKDfYT.html

 

Ventilators

http://www.ox.ac.uk/news/2020-03-31-ventilator-project-oxvent-gets-green-light-uk-government-proceed-next-stage-testing

https://www.dyson.co.uk/newsroom/overview/update/ventilator-update.html

Research

 

Genetic sequences

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30251-8/fulltext

https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&VirusLineage_ss=SARS-CoV-2,%20taxid:2697049

https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/

https://mra.asm.org/content/9/11/e00169-20

 

Tests

Other

https://www.research.ox.ac.uk/Area/coronavirus-research

https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html

https://www.nih.gov/news-events/news-releases/nih-clinical-trial-testing-antiviral-remdesivir-plus-anti-inflammatory-drug-baricitinib-covid-19-begins

https://bestpractice.bmj.com/topics/en-gb/3000168/emergingtxs

Vaccines

 

https://www.who.int/news-room/commentaries/detail/immunity-passports-in-the-context-of-covid-19

  • WHO has published guidance on adjusting public health and social measures for the next phase of the COVID-19 response.1 Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an “immunity passport” or “risk-free certificate” that would enable individuals to travel or to return to work assuming that they are protected against re-infection. There is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection.

https://www.nature.com/articles/d41573-020-00073-5

http://www.ox.ac.uk/news/2020-04-23-oxford-covid-19-vaccine-begins-human-trial-stage

 

Remote

 

Teams

AccuRx

Comments are closed.